Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Immatics N.V.

Immatics N.V. (IMTX) Stock Overview

Explore Immatics N.V.’s financial performance, market position, analyst ratings, and future outlook.

IMTX●NASDAQ
HealthcareBiotechnology
$8.63
$0.45(4.96%)
U.S. Market opens in 15h 20m

Immatics N.V. (IMTX)

Meyka AI Score

Z

Key Financials

Market Cap1.2B
P/E Ratio-4.54
EPS (TTM)$-1.99
ROE-0.45%
Fundamental Analysis

AI Price Forecasts

1 Month$8.54
3 Months$12.52
1 Year Target$9.27

IMTX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Immatics N.V. (NASDAQ: IMTX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Immatics N.V.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of IMTX on the NASDAQ shows an RSI of 35.48, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $9.27 for the NASDAQ listing.

Key metrics behind Immatics N.V.'s NASDAQ-traded stock include a P/E ratio of -4.54 and a market capitalization of 1.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of IMTX on the NASDAQ.

Price Performance (NASDAQ: IMTX)

1-Day Change
-4.96%
5-Day Change
-6.90%
1-Month Change
-9.35%
3-Month Change
-23.96%
6-Month Change
-13.61%
Year-to-Date (YTD) Change
-17.81%
1-Year Change
29.39%
3-Year Change
-24.63%
5-Year Change
-28.38%
All-Time (Max) Change
-10.10%

Contact Information

https://www.immatics.com
49 7071 5397 0
Paul-Ehrlich-Strasse 15, Tübingen, BW, 72076

Company Facts

4,070 Employees
IPO DateDec 12, 2018
CountryDE
Actively Trading

Frequently Asked Questions